In this population-based study among postmenopausal women, we observed that IgM anti-PC may be a marker of protection against incident composite CVD, mainly for IHD and MI, with the latter corresponding to a multivariable-adjusted 73% (95% CI: 32%-89%) lower risk in the highest compared to lowest tertile. This evidence concerns the gene CD40LG and myocardial ischemia.